Foundations in Continuing Education

Substance Abuse and Chemical Dependency

Appendices


Chapter 1: Background Terminology

Chapter 2: Epidemiology

Chapter 3: Pathophysiology of Addiction

Chapter 4: Classification and Characteristics of Psychoactive Substances

Chapter 5: Treatment

Chapter 6: Identification of the Abusing Patient

Chapter 7: Implications for Dental Treatment

Chapter 8: Impaired Oral Health Team Members

Chapter 9: Conclusion

Appendix A: Glossary
Appendix B: Common
Slang Terms

Appendix C: Online
Resources

Appendix D: Treatment
and Informational
Related Resources

Appendix E: References
Appendix F: American
Psychiatric Assoc.
Diagnostic and
Statistical Manual of
Mental Disorders
(DSM-IV-TR)

Appendix G: Schedules
of Controlled
Substances

Appendix H: Substance
Abuse Community
Referral Resources

Post Examination

Exit to Menu





Appendix G: Schedules of Controlled Substances

The Controlled Substances Act (CSA), Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, provides the legal foundation for regulation and enforcement of laws pertaining to the manufacture and distribution of drugs. All drugs are placed in one of five schedules. Prescription authority of health care providers is based on this schedule.

According to the DEA, these lists are intended as general references and are not comprehensive listings of all controlled substances.

Schedule I

  • Drug or other substance has a high potential for abuse
  • Drug or other substance has no currently accepted medical use
  • Lack of accepted safety for use of the drug or substance under medical supervision (Examples: Marijuana, Heroin, and LSD)

Schedule II

  • Drug or other substance has high potential for abuse
  • Drug or other substance has a currently accepted medical use in treatment
  • Abuse of the drug or substance may lead to psychological or physical dependence (Examples: Cocaine, Percocet®, Ritalin®, Demerol®, Morphine, Fentanyl®, Adderall, and Oxycontin)

Schedule III

  • Drug or other substance has a potential for abuse less than the drugs or other substances in schedules II or I
  • Drug or other substance has a currently accepted medical use in treatment
  • Abuse of the drug or other substance may lead to a moderate or low physical dependence or high psychological dependence (Examples: Opium (may be schedule IV depending on amount of opium), Vicodin®, Tylenol w/codeine, Vicoprofin, buprenorphrine, and some amphetamines)

Schedule IV

  • Drug or other substance has a low potential for abuse relative to drugs or substances in schedule III
  • Drug or substance has a currently accepted medical use
  • Abuse of the drug or substance may lead to limited physical or psychological dependence compared to drugs or substances in schedule III (Examples: Darvocet®, Valium®, Xanax®, Ativan®, Talwin-NX®, Phenobarbital, and Halcion®)

Schedule V

  • Drug or other substance has a low potential for abuse compared to the drugs or substances in schedule IV
  • Drug or substance has a currently accepted medical use
  • Abuse of the drug or substance may lead to a limited physical or psychological dependence (Examples: Lomotil®, Phenergan®, Robitussin AC)

http://www.deadiversion.usdoj.gov/schedules/listby_sched/sched1.htm retrieved April 24, 2007.

Continue on to Appendix H: Substance Abuse Community Referral Resources